Did you know that acute myeloid leukemia (AML) is the most common type of acute leukemia in adults? Nearly 40,000 people are diagnosed with AML in the U.S. and Europe each year, and for those patients outcomes are typically poor. Despite dramatic advances in other blood cancers, AML has not seen a change in the standard of therapy in the past 40 years and new treatment options are desperately needed.
In recognition of AML Day, 21 April, The MDS Alliance, The Leukemia & Lymphoma Society and Patient Power invite you to join a panel discussion on:
TIME: 11 a.m. ET / 5 p.m. CEST
REGISTER: www.bit.ly/AMLDay
